[go: up one dir, main page]

AU2270695A - Active compounds - Google Patents

Active compounds

Info

Publication number
AU2270695A
AU2270695A AU22706/95A AU2270695A AU2270695A AU 2270695 A AU2270695 A AU 2270695A AU 22706/95 A AU22706/95 A AU 22706/95A AU 2270695 A AU2270695 A AU 2270695A AU 2270695 A AU2270695 A AU 2270695A
Authority
AU
Australia
Prior art keywords
active compounds
compounds
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU22706/95A
Inventor
Carin Birgitta Briving
Mats Peter Nordberg
Carl Ingemar Starke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU2270695A publication Critical patent/AU2270695A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22706/95A 1994-04-11 1995-04-07 Active compounds Withdrawn AU2270695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9401197 1994-04-11
SE9401197A SE9401197D0 (en) 1994-04-11 1994-04-11 Active compounds
PCT/SE1995/000376 WO1995027714A1 (en) 1994-04-11 1995-04-07 Active compounds

Publications (1)

Publication Number Publication Date
AU2270695A true AU2270695A (en) 1995-10-30

Family

ID=20393591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22706/95A Withdrawn AU2270695A (en) 1994-04-11 1995-04-07 Active compounds

Country Status (6)

Country Link
AU (1) AU2270695A (en)
IL (1) IL113263A0 (en)
IS (1) IS4274A (en)
SE (1) SE9401197D0 (en)
WO (1) WO1995027714A1 (en)
ZA (1) ZA952860B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289542A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
SK285165B6 (en) * 1998-09-23 2006-07-07 Altana Pharma Ag Tetrahydropyridoethers, pharmaceutical composition containing same and use thereof
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CN1213049C (en) * 2000-03-29 2005-08-03 奥坦纳医药公司 Alkylated imidazopyridine derivatives
NZ520837A (en) * 2000-03-29 2005-01-28 Altana Pharma Ag Prodrugs of imidazopyridine derivatives
EP1286999B1 (en) * 2000-03-29 2007-12-19 Nycomed GmbH PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
DE60127131T2 (en) * 2000-03-29 2007-11-22 Nycomed Gmbh TRICYCLIC IMIDAZOPYRIDINE
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
US20040235883A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
HRP20040229A2 (en) * 2001-08-10 2005-02-28 Altana Pharma Ag Tricyclic imidazopyridines
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
RS20050730A (en) 2003-04-04 2007-11-15 Altana Pharma Ag., Cyclid benzimidazoles
WO2005058894A1 (en) * 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AU2005223389A1 (en) * 2004-03-17 2005-09-29 Altana Pharma Ag 7H-8,9-dihydro-pyrano (2,3-C) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines

Also Published As

Publication number Publication date
SE9401197D0 (en) 1994-04-11
ZA952860B (en) 1996-01-12
IL113263A0 (en) 1995-10-31
IS4274A (en) 1995-10-12
WO1995027714A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
GB9510757D0 (en) Therapeuticaly active compounds
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU3304995A (en) 2-Hydroxyphenyltriazines
AU2270695A (en) Active compounds
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
AU2308295A (en) Heterocyclylbenzonitriles
AU5693596A (en) Active compound combinations
AU3855995A (en) Optically active compound
AU3554995A (en) Antipicornaviral agents
AU1963395A (en) Boom-structure
AU4399396A (en) Compounds
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU3856995A (en) UCF116 Compounds
AU4590996A (en) Boekomslag
AU1093697A (en) Active bio-compounds
AU3446995A (en) Biodestumping
AU3166095A (en) Benzylimidazopyridines
AU1603595A (en) Meso-azanoradamantanes
AU2411395A (en) Hydrocopter
AU2301295A (en) Guanidino-substituted compounds